Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Lai
Bevacizumab and Chemotherapy for Recurrent Glioblastoma: A Single-Institution Experience
Neurology
Neurology
Effect of Age on Recovery From Remifentanil Anaesthesia
Anaesthesia and Intensive Care
Critical Care
Anesthesiology
Pain Medicine
Intensive Care Medicine
‹
1
2
3
Related publications
Radiosurgery for Recurrent Glioblastoma Multiforme: A Single Institution Experience
Canadian Journal of Neurological Sciences
Medicine
Neurology
Single-Institution Retrospective Review of Patients With Recurrent Glioblastoma Treated With Bevacizumab in Clinical Practice
Health Science Reports
Addition of Lomustine for Bevacizumab-Refractory Recurrent Glioblastoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Erratum To: Single-Agent Bevacizumab Is an Effective Treatment in Recurrent Glioblastoma
Medical Oncology
Medicine
Cancer Research
Oncology
Hematology
Sustained Focal Antitumor Activity of Bevacizumab in Recurrent Glioblastoma
Neurology
Neurology
Angiotensinogen and HLA Class II Predict Bevacizumab Response in Recurrent Glioblastoma Patients
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Primary Chemotherapy With Adriamycin, Cisplatin, Vincristine and Cyclophosphamide in Locally Advanced Thymomas: A Single Institution Experience
British Journal of Cancer
Cancer Research
Oncology
Bevacizumab for Recurrent Hemangioendothelioma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Bevacizumab and Fotemustine for Recurrent Glioblastoma: A Phase II Study of AINO (Italian Association of Neuro-Oncology)
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology